56
Koselugo 25mg Capsules: A Breakthrough for NF1 Patients with Plexiform Neurofibromas?
Koselugo 25mg Capsules have been recently approved for treating children with Neurofibromatosis Type 1 (NF1) who have plexiform neurofibromas (PNs). This condition can cause significant issu…
9 comments
194 views